RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189 | -29.7% | 22,447 | +4.9% | 0.00% | -50.0% |
| Q2 2023 | $269 | -32.6% | 21,405 | -11.6% | 0.00% | -33.3% |
| Q1 2023 | $399 | +12.1% | 24,208 | +1.6% | 0.00% | 0.0% |
| Q4 2022 | $356 | -99.9% | 23,820 | +0.1% | 0.00% | -25.0% |
| Q3 2022 | $532,000 | +202.3% | 23,797 | +126.9% | 0.00% | +300.0% |
| Q2 2022 | $176,000 | -33.1% | 10,488 | +19.5% | 0.00% | 0.0% |
| Q1 2022 | $263,000 | +7.8% | 8,775 | +10.3% | 0.00% | 0.0% |
| Q4 2021 | $244,000 | – | 7,956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |